The primary focus of our group is to design new concepts for early cancer detection and precision management with novel biomarkers and test technologies. Our research combines biomarker discovery, antibody and assay development and clinical validation addressing various cancers. The research group is a blend of experienced researchers, early-stage researchers and technicians led by docent Janne Leivo and emeritus professor Kim Pettersson.

Read more: earlycancerdiagnostics.utu.fi